162 related articles for article (PubMed ID: 37309193)
21. Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study.
Ruigómez A; Johansson S; Nagy P; García Rodríguez LA
Curr Med Res Opin; 2017 Dec; 33(12):2201-2209. PubMed ID: 28699796
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.
Kinoshita Y; Chiba T;
J Gastroenterol; 2012 Apr; 47(4):377-86. PubMed ID: 22183857
[TBL] [Abstract][Full Text] [Related]
27. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
[TBL] [Abstract][Full Text] [Related]
28. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y
Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392
[TBL] [Abstract][Full Text] [Related]
29. Helicobacter gastritis induces changes in the oxyntic mucosa indistinguishable from the effects of proton pump inhibitors.
Kumar KR; Iqbal R; Coss E; Park C; Cryer B; Genta RM
Hum Pathol; 2013 Dec; 44(12):2706-10. PubMed ID: 24071014
[TBL] [Abstract][Full Text] [Related]
30. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
31. Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
Arbel Y; Birati EY; Finkelstein A; Halkin A; Kletzel H; Abramowitz Y; Berliner S; Deutsch V; Herz I; Keren G; Banai S
Clin Cardiol; 2013 Jun; 36(6):342-6. PubMed ID: 23630016
[TBL] [Abstract][Full Text] [Related]
32. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
33. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2001; (4):CD002095. PubMed ID: 11687139
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.
Zhang JX; Ji MY; Song J; Lei HB; Qiu S; Wang J; Ai MH; Wang J; Lv XG; Yang ZR; Dong WG
World J Gastroenterol; 2013 Dec; 19(45):8408-19. PubMed ID: 24363534
[TBL] [Abstract][Full Text] [Related]
36. Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.
Sakaguchi M; Takao M; Ohyama Y; Oka H; Yamashita H; Fukuchi T; Ashida K; Murotani M; Murotani M; Majima K; Morikawa H; Hashimoto T; Kiyota K; Esaki H; Amemoto K; Isowa G; Takao F
World J Gastroenterol; 2012 Apr; 18(13):1517-24. PubMed ID: 22509084
[TBL] [Abstract][Full Text] [Related]
37. Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial.
Wehmeyer MH; Horvatits T; Buchholz A; Krause L; Walter S; Zapf A; Lohse AW; Kluwe J;
Trials; 2022 Apr; 23(1):302. PubMed ID: 35414106
[TBL] [Abstract][Full Text] [Related]
38. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
Soga T; Matsuura M; Kodama Y; Fujita T; Sekimoto I; Nishimura K; Yoshida S; Kutsumi H; Fujimoto S
J Gastroenterol; 1999 Aug; 34(4):435-40. PubMed ID: 10452673
[TBL] [Abstract][Full Text] [Related]
39. Poor awareness of preventing aspirin-induced gastrointestinal injury with combined protective medications.
Zhu LL; Xu LC; Chen Y; Zhou Q; Zeng S
World J Gastroenterol; 2012 Jun; 18(24):3167-72. PubMed ID: 22791953
[TBL] [Abstract][Full Text] [Related]
40. A Randomized, Double-blind, Active-Controlled, Multi-center Study of Ilaprazole in the Treatment of Reflux Esophagitis.
Xue Y; Qin X; Zhou L; Lin S; Wang L; Hu H; Xia J
Clin Drug Investig; 2016 Dec; 36(12):985-992. PubMed ID: 27605258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]